Trending

Galapagos

Novartis pays up to $1 billion for potential eczema drug

Novartis pays up to $1 billion for potential eczema drug

Swiss pharma Novartis is to pay up to $1 billion to Galapagos and MorphoSys for exclusive rights to

X

Novartis pays up to $1 billion for potential eczema drug

https://pharmaphorum.com/news/novartis-increases-its-immunology-footprint-with-1-billion-deal/

Gilead could make a move for Galapagos within weeks

Gilead could make a move for Galapagos within weeks

The share price of Belgium-Dutch biotech Galapagos is rising thanks to renewed speculation that Gilead may be poised

X

Gilead could make a move for Galapagos within weeks

https://pharmaphorum.com/news/gilead-make-move-galapagos-within-weeks/

Galapagos and FibroGen drugs offer hope in IPF

Galapagos and FibroGen drugs offer hope in IPF

Drugs improve on existing medicines from Boehringer and Roche.

X

Galapagos and FibroGen drugs offer hope in IPF

https://pharmaphorum.com/news/galapagos-fibrogen-ipf/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com